Silynxcom director Gal Nir Klein buys shares
The VP Marketing & Israel Sales purchases were held jointly with spouse Nir Klein, who is also a reporting person.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Silynxcom Ltd. director and VP Marketing & Israel Sales Gal Nir Klein reported two purchases of ordinary shares: 10,000 shares on November 3, 2026, at a weighted average price of $0.9807 per share, and 9,940 shares on November 4, 2026, at a weighted average price of $0.9960 per share. The purchases comprised multiple transactions at prices ranging from $0.9500 to $1.0000 and from $0.9750 to $1.0000, respectively. The shares were held jointly with right of survivorship with Mr. Nir Klein, who is also a reporting person; they share control and pecuniary interest. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Ordinary Shares, no par value per share F3, F1 | 9,940 | $0.996 | $10K |
| Purchase | Ordinary Shares, no par value per share F2, F1 | 10,000 | $0.9807 | $10K |
Footnotes (3)
- F1. Held as joint tenants with right of survivorship with Mrs. Klein's spouse, Mr. Nir Klein, who is also a reporting person of Silynxcom Ltd. (the "Issuer"), and over which they share control and pecuniary interest.
- F2. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions on November 3, 2026 at prices ranging from $0.9500 to $1.0000 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- F3. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions on November 4, 2026 at prices ranging from $0.9750 to $1.0000 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
weighted average price financial
right of survivorship regulatory
pecuniary interest regulatory
Rule 10b5-1 plan regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.